. FAP patients inherit a mutated copy of the adenomatous polyposis coli (APC) gene (1-3), whereas hereditary nonpolyposis CRC is caused by inheritance of defective DNA mismatch repair genes such as MSH2 or MLH1 (4, 5). However, hereditary nonpolyposis CRC and FAP account for only a small fraction of the colorectal tumors presenting in the human population. The vast majority of CRCs (Ϸ80%) do not result from a known inherited factor, are considered sporadic in origin, and demonstrate somatic mutation of the APC gene (6-10).Many studies have suggested a role for uncharacterized genetic factors in predisposition to the common forms of colorectal tumors. Thus, relatives of CRC patients are at an increased risk of the disease, and segregation analysis has suggested dominant inheritance of CRC susceptibility (11,12). In addition, an extensive analysis of twins showed that up to one-third of CRCs may have some inherited basis (13). The remaining, uncharacterized predisposition to CRC in humans is more likely to be the result of several genes of low-penetrance rather than highpenetrance mutations at single loci with large effects on risk (14). Much of the risk of CRC may result from a primary predisposition to colorectal adenomas. The number of colorectal adenomas presenting within FAP families or individuals with identical germ-line APC mutations has been shown to vary, suggesting that hereditary factors also may influence disease severity (15). The same genes that modify the phenotype of individuals with FAP also may influence the risk of CRC in the general population. A search for FAP modifier genes, either directly or through rodent models, therefore may lead to the identification of important susceptibility genes for human CRC.The first mouse model used to study the involvement of the Apc gene in CRC is referred to as Min (Multiple intestinal neoplasia). Apc Min/ϩ (Min) mice are heterozygous for a truncating Apc mutation and develop numerous intestinal adenomas, thereby providing a good model of human FAP. The Min model has been used to provide an unambiguous example of a modifying locus in mice. A single locus was identified as a consequence of significant variation in the polyp number, depending on the inbred mouse strain harboring the Apc mutation. Linkage analysis located Mom1 on mouse chromosome 4, and further analysis identified the secretory phospholipase A2 (Pla2g2a) as a candidate gene (16)(17)(18). Unfortunately, studies in humans did not confirm PLA2G2A as a major modifier of colorectal cancer risk in humans because functional polymorphic variation did not exist (19,20). A second locus, Mom2, on distal chromosome 18 was identified by Silverman et al. (21), although the underlying genetic defect has yet to be established. We now have direct evidence of a further Mom locus controlling susceptibility to a particularly severe form of intestinal disease in Min mice.
Materials and MethodsHusbandry. Mice were housed in conventional cages, and a standard maintenance diet was provided ad libitum. All procedures i...